CERO THERAPEUTICS HOLDINGS, INC. - 10-Q Filing

Cero Therapeutics Holdings, Inc. reports Q3 financial results and discloses significant subsequent events including a legal settlement and Series E preferred stock agreements.

SEC EDGAR ·

Tickers: $PBAXU

Read the full article at SEC EDGAR

More Regulatory news